MedPage Today on MSN
Menopause Hormone Therapy May Boost GLP-1 Drug Benefits
Tirzepatide users on hormone therapy had added improvements in weight, cardiometabolic mar ...
Menopausal hormone replacement therapy (MHT) was once routinely used to relieve symptoms of menopause and protect against ...
Researchers in Canada reported in Neurology that transdermal estradiol improved episodic memory scores in postmenopausal ...
A new study led by Mayo Clinic found that postmenopausal women receiving menopausal hormone therapy lost 35% more weight ...
Women diagnosed with premature ovarian insufficiency (POI) are at risk for more health problems than women who enter ...
If you've ever tried to lose weight with a partner, you've probably seen the maddening and frustrating difference- he goes without bread for a week and loses 10 pounds, yet you do the same thing and ...
GLP-1 receptor agonists—the popular class of weight-loss drugs that include semaglutide (Ozempic)—may carry underrecognized risks for women of reproductive age, according to new research from ...
Long-acting cabotegravir and rilpivirine (CAB/RPV) administered intramuscularly monthly or every 2 months yielded high rates of efficacy and a favorable safety profile in women with HIV, according to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results